CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart...
Los Angeles, California, United States of America and 46 other locations
) application in patients with symptomatic heart disease due to failure of a surgical or transcatheter bioprosthetic aortic valve w...
Thousand Oaks, California, United States and 107 other locations
Familial Hypercholesterolemia (HeFH) or Premature Coronary Artery Disease (CAD) Who Require Additional Lowering of LDL-C. VERVE-102 Uses Bas...
Phase 1
Pomona, California, United States and 26 other locations
study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that part of the heart...
Los Angeles, California, United States and 9 other locations
A phase III study designed as a randomized, within-patient comparison of continuous infusion of diluted Lumason® versus the bolus administration of u...
Phase 3
West Hills, California, United States of America and 5 other locations
of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial).The study contains of 5 a...
Los Angeles, California, United States and 50 other locations
Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect
Los Angeles, California, United States and 31 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Los Angeles, California, United States and 39 other locations
Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.
Los Angeles, California, United States and 84 other locations
Prospective, single-arm, multi-center, continued access study of the Autus Size-Adjustable Valve in pediatric patients aged 18 months to 16 years req...
Los Angeles, California, United States and 9 other locations
Clinical trials
Research sites
Resources
Legal